LYSRUPTO
Pharmaceutical preparations for the treatment of Gram-positive bacterial infection, including, but not limited to, Staphylococcus aureus infection; pharmaceutical preparations for the treatment of drug-resistant strains of bacteria, including antibiotic-resistance bacterial infection; and pharmaceutical preparations for the treatment of infections related to Gram-positive bacteria and drug-resistant strains of bacteria, including, but not limited to, Staphylococcus aureus blood stream infecti...
Pending · November 17, 2021 · 97129252 ·